Literature DB >> 21890145

A sensitive and simple ultra-high-performance-liquid chromatography-tandem mass spectrometry based method for the quantification of D-amino acids in body fluids.

Wouter F Visser1, Nanda M Verhoeven-Duif, Roel Ophoff, Steven Bakker, Leo W Klomp, Ruud Berger, Tom J de Koning.   

Abstract

D-Amino acids are increasingly being recognized as important signaling molecules in mammals, including humans. D-Serine and D-aspartate are believed to act as signaling molecules in the central nervous system. Interestingly, several other D-amino acids also occur in human plasma, but very little is currently known regarding their function and origin. Abnormal levels of D-amino acids have been implicated in the pathogenesis of different diseases, including schizophrenia and amyotrophic lateral sclerosis (ALS), indicating that D-amino acid levels hold potential as diagnostic markers. Research into the biological functions of D-amino acids is hindered, however, by the lack of sufficiently sensitive, high-throughput analytical methods. In particular, the interference of large amounts of L-amino acids in biological samples and the low concentrations of D-amino acids are challenging. In this paper, we compared 7 different chiral derivatization agents for the analysis of D-amino acids and show that the chiral reagent (S)-NIFE offers outstanding performance in terms of sensitivity and enantioselectivity. An UPLC-MS/MS based method for the quantification of D-amino acids human biological fluids was then developed using (S)-NIFE. Baseline separation (R(s)>2.45) was achieved for the isomers of all 19 chiral proteinogenic amino acids. The limit of detection was <1 nM for all amino acids except d-alanine (1.98 nM), d-methionine (1.18 nM) and d-asparagine (5.15 nM). For measurements in human plasma, cerebrospinal fluid and urine, the accuracy ranged between 85% and 107%. The intra-assay and inter-assay were both <16% RSD for these three different matrices. Importantly, the method does not suffer from spontaneous racemization during sample preparation and derivatization. Using the described method, D-amino acid levels in human cerebrospinal fluid, plasma and urine were measured.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21890145     DOI: 10.1016/j.chroma.2011.07.087

Source DB:  PubMed          Journal:  J Chromatogr A        ISSN: 0021-9673            Impact factor:   4.759


  21 in total

1.  Genome-wide association study of NMDA receptor coagonists in human cerebrospinal fluid and plasma.

Authors:  J J Luykx; S C Bakker; W F Visser; N Verhoeven-Duif; J E Buizer-Voskamp; J M den Heijer; M P M Boks; J H Sul; E Eskin; A P Ori; R M Cantor; J Vorstman; E Strengman; J DeYoung; T H Kappen; E Pariama; E P A van Dongen; P Borgdorff; P Bruins; T J de Koning; R S Kahn; R A Ophoff
Journal:  Mol Psychiatry       Date:  2015-02-10       Impact factor: 15.992

2.  The sleep-promoting and hypothermic effects of glycine are mediated by NMDA receptors in the suprachiasmatic nucleus.

Authors:  Nobuhiro Kawai; Noriaki Sakai; Masashi Okuro; Sachie Karakawa; Yosuke Tsuneyoshi; Noriko Kawasaki; Tomoko Takeda; Makoto Bannai; Seiji Nishino
Journal:  Neuropsychopharmacology       Date:  2014-12-23       Impact factor: 7.853

3.  LC-MS/MS-Based Separation and Quantification of Marfey's Reagent Derivatized Proteinogenic Amino Acid DL-Stereoisomers.

Authors:  Navid J Ayon; Amar Deep Sharma; William G Gutheil
Journal:  J Am Soc Mass Spectrom       Date:  2018-11-12       Impact factor: 3.109

Review 4.  Investigating brain d-serine: Advocacy for good practices.

Authors:  Jean-Pierre Mothet; Jean-Marie Billard; Loredano Pollegioni; Joseph T Coyle; Jonathan V Sweedler
Journal:  Acta Physiol (Oxf)       Date:  2019-02-14       Impact factor: 6.311

5.  A common variant in ERBB4 regulates GABA concentrations in human cerebrospinal fluid.

Authors:  Jurjen J Luykx; Christiaan H Vinkers; Steven C Bakker; Wouter F Visser; Loes van Boxmeer; Eric Strengman; Kristel R van Eijk; Judith A Lens; Paul Borgdorff; Peter Keijzers; Teus H Kappen; Eric P A van Dongen; Peter Bruins; Nanda M Verhoeven; Tom J de Koning; René S Kahn; Roel A Ophoff
Journal:  Neuropsychopharmacology       Date:  2012-05-02       Impact factor: 7.853

6.  Identification of a human trans-3-hydroxy-L-proline dehydratase, the first characterized member of a novel family of proline racemase-like enzymes.

Authors:  Wouter F Visser; Nanda M Verhoeven-Duif; Tom J de Koning
Journal:  J Biol Chem       Date:  2012-04-23       Impact factor: 5.157

7.  D-amino acid aberrations in cerebrospinal fluid and plasma of smokers.

Authors:  Jurjen J Luykx; Steven C Bakker; Loes van Boxmeer; Christiaan H Vinkers; Hanne E Smeenk; Wouter F Visser; Nanda M Verhoeven-Duif; Eric Strengman; Jacobine E Buizer-Voskamp; Lizzy de Groene; Eric Pa van Dongen; Paul Borgdorff; Peter Bruins; Tom J de Koning; René S Kahn; Roel A Ophoff
Journal:  Neuropsychopharmacology       Date:  2013-04-24       Impact factor: 7.853

8.  An update on serine deficiency disorders.

Authors:  S N van der Crabben; N M Verhoeven-Duif; E H Brilstra; L Van Maldergem; T Coskun; E Rubio-Gozalbo; R Berger; T J de Koning
Journal:  J Inherit Metab Dis       Date:  2013-03-06       Impact factor: 4.982

9.  Role of d-amino acid oxidase in the production of kynurenine pathway metabolites from d-tryptophan in mice.

Authors:  Francesca M Notarangelo; Xiao-Dan Wang; Kyle J Horning; Robert Schwarcz
Journal:  J Neurochem       Date:  2016-01-13       Impact factor: 5.372

10.  Development and validation of a sensitive LC-MS/MS method for the determination of D-serine in human plasma.

Authors:  Y Xie; G M Alexander; R J Schwartzman; M C Torjman; M E Goldberg; I W Wainer; R Moaddel
Journal:  J Pharm Biomed Anal       Date:  2013-10-30       Impact factor: 3.935

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.